文献速递消化道肿瘤与早癌消化内镜

自膨式金属支架治疗恶性食管呼吸道瘘:与临床失败相关的预测因素

Self-expandable metal stent for malignant esophagorespiratory fistula: predictive factors associated with clinical failure.
PubMed 文献 · Gastrointest Endosc · 2017-09-28

该回顾性分析基于一家三级癌症医院2009年1月至2016年2月的前瞻性维护数据库,纳入71例接受自膨式金属支架置入的恶性食管呼吸道瘘患者,最终分析70例。临床失败率为44%,ECOG体能状态3或4分及食管癌治疗期间发生瘘与临床失败风险增加相关;支架置入后15天吞咽困难评分显著改善,支架相关不良事件率为30%。

要点

  • ECOG体能状态3或4分及食管癌治疗期间发生瘘与支架置入后临床失败风险增加相关。
  • ECOG 3或4分、支架置入时肺部感染及既往放疗与总生存期较低相关。
  • 支架置入后15天吞咽困难评分显著改善;支架相关不良事件率为30%。

核心结论

  • 自膨式金属支架置入是恶性食管呼吸道瘘的合理治疗选择;但ECOG体能状态3或4分及食管癌治疗期间发生瘘可能是支架置入后临床失败的独立预测因素。

研究设计与样本

  • 回顾性分析一家三级癌症医院前瞻性维护的数据库,纳入2009年1月至2016年2月因恶性食管呼吸道瘘接受自膨式金属支架置入的患者71例(55例男性,平均年龄59岁),最终分析70例(1例支架置入失败)。

主要发现

  • 临床失败发生于44%的患者。
  • ECOG体能状态3或4分及食管癌治疗期间发生瘘与临床失败风险增加相关。
  • ECOG体能状态3或4分、支架置入时肺部感染及既往放疗是与总生存期较低相关的预测因素。
  • 支架置入后15天吞咽困难评分显著改善。
  • 支架相关不良事件总发生率为30%,支架移位和肿瘤过度生长导致的支架闭塞是最常见的不良事件。

临床怎么用

  • 原文结论认为自膨式金属支架置入是恶性食管呼吸道瘘的合理治疗选择。
  • 原文指出ECOG体能状态3或4分及食管癌治疗期间发生瘘可能是支架置入后临床失败的独立预测因素。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Malignant esophagorespiratory fistulas (MERFs) usually are managed by the placement of self-expandable metal stents (SEMSs) but with conflicting results. This study aimed to identify risk factors associated with clinical failure after SEMS placement for the treatment of MERFs. METHODS: This was a retrospective analysis of a prospectively maintained database used at a tertiary-care cancer hospital, with patients treated with SEMS placement for MERFs between January 2009 and February 2016. Logistic regression was used to identify predictive factors for clinical outcomes and to estimate the odds ratio (OR) and the 95% confidence interval (CI). The Kaplan-Meier method was used for survival analysis, and comparisons were made by using the log-rank test. RESULTS: A total of 71 patients (55 male, mean age 59 years) were included in the study, and 70 were considered for the final analysis (1 failed stent insertion). Clinical failure occurred in 44% of patients. An Eastern Cooperative Oncology Group (ECOG) performance status of 3 or 4 and fistula development during esophageal cancer treatment were associated with an increased risk of clinical failure. ECOG status of 3 or 4, pulmonary infection at the time of SEMS placement, and prior radiation therapy were predictive factors associated with lower overall survival. Dysphagia scores improved significantly 15 days after stent insertion. The overall stent-related adverse event rate was 30%. Stent migration and occlusion caused by tumor overgrowth were the most common adverse events. CONCLUSION: SEMS placement is a reasonable treatment option for MERFs; however, ECOG status of 3 or 4 and fistula development during esophageal cancer treatment may be independent predictors of clinical failure after stent placement.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Ribeiro MSI, da Costa Martins B, Simas de Lima M, et al. Self-expandable metal stent for malignant esophagorespiratory fistula: predictive factors associated with clinical failure. Gastrointest Endosc. 2017. PMID: 28964748. doi:10.1016/j.gie.2017.09.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。